Found: 40
Select item for more details and to access through your institution.
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 3, p. 374, doi. 10.3390/ph15030374
- By:
- Publication type:
- Article
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3739, doi. 10.3390/ijms24043739
- By:
- Publication type:
- Article
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity?
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 7, p. 3553, doi. 10.3390/ijms23073553
- By:
- Publication type:
- Article
Autoinflammatory Diseases and Cytokine Storms—Imbalances of Innate and Adaptative Immunity.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 20, p. 11241, doi. 10.3390/ijms222011241
- By:
- Publication type:
- Article
MitoQ Is Able to Modulate Apoptosis and Inflammation.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 9, p. 4753, doi. 10.3390/ijms22094753
- By:
- Publication type:
- Article
A novel endovenous scaffold for the treatment of chronic venous obstruction in a porcine model: Histological and ultrastructural assessment.
- Published in:
- Phlebology, 2019, v. 34, n. 5, p. 336, doi. 10.1177/0268355518805686
- By:
- Publication type:
- Article
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors.
- Published in:
- Current Oncology, 2021, v. 28, n. 4, p. 2439, doi. 10.3390/curroncol28040223
- By:
- Publication type:
- Article
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy.
- Published in:
- Mediators of Inflammation, 2015, v. 2015, p. 1, doi. 10.1155/2015/942948
- By:
- Publication type:
- Article
MDM2 Antagonist Nutlin-3 Suppresses the Proliferation and Differentiation of Human Pre-Osteoclasts Through a p53-Dependent Pathway.
- Published in:
- Journal of Bone & Mineral Research, 2007, v. 22, n. 10, p. 1621, doi. 10.1359/JBMR.070618
- By:
- Publication type:
- Article
Circulating TRAIL Shows a Significant Post-Partum Decline Associated to Stressful Conditions.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0027011
- By:
- Publication type:
- Article
Human Colostrum and Breast Milk Contain High Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Human Colostrum and Breast Milk Contain High Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL).
- Published in:
- Journal of Human Lactation, 2013, v. 29, n. 1, p. 23, doi. 10.1177/0890334412441071
- By:
- Publication type:
- Article
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 15, p. 9061, doi. 10.3390/ijerph19159061
- By:
- Publication type:
- Article
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells.
- Published in:
- Journal of Cellular Biochemistry, 2008, v. 104, n. 2, p. 595, doi. 10.1002/jcb.21649
- By:
- Publication type:
- Article
Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment.
- Published in:
- Dementia & Geriatric Cognitive Disorders, 2016, v. 41, n. 5/6, p. 273, doi. 10.1159/000446275
- By:
- Publication type:
- Article
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 10, p. 1438, doi. 10.3390/biom11101438
- By:
- Publication type:
- Article
Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3605, doi. 10.3390/cancers15143605
- By:
- Publication type:
- Article
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 3, p. 780, doi. 10.1007/s10637-012-9903-x
- By:
- Publication type:
- Article
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells.
- Published in:
- 2012
- By:
- Publication type:
- Report
Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAIL.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 828, doi. 10.1007/s10637-010-9599-8
- By:
- Publication type:
- Article
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines.
- Published in:
- 2011
- By:
- Publication type:
- Report
Synthesis and Biological Investigation of Bile Acid-Paclitaxel Hybrids.
- Published in:
- Molecules, 2022, v. 27, n. 2, p. 471, doi. 10.3390/molecules27020471
- By:
- Publication type:
- Article
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients.
- Published in:
- Life Science Alliance, 2023, v. 6, n. 5, p. 1, doi. 10.26508/lsa.202201786
- By:
- Publication type:
- Article
Soluble TRAIL does not impair the anti-osteoclastic activity of osteoprotegerin.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL) Modulates the Expression of Genes Involved in Apoptosis and Cell Cycle in Human Osteoclasts.
- Published in:
- Anatomical Record: Advances in Integrative Anatomy & Evolutionary Biology, 2007, v. 290, n. 7, p. 838, doi. 10.1002/ar.20550
- By:
- Publication type:
- Article
GM-CSF Exhibits Anti-Inflammatory Activity on Endothelial Cells Derived from Chronic Venous Disease Patients.
- Published in:
- Mediators of Inflammation, 2013, v. 2013, p. 1, doi. 10.1155/2013/561689
- By:
- Publication type:
- Article
Inhibitory Effect of Natural Anti-Inflammatory Compounds on Cytokines Released by Chronic Venous Disease Patient-Derived Endothelial Cells.
- Published in:
- Mediators of Inflammation, 2013, v. 2013, p. 1, doi. 10.1155/2013/423407
- By:
- Publication type:
- Article
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages.
- Published in:
- Journal of Cellular Physiology, 2012, v. 227, n. 5, p. 1829, doi. 10.1002/jcp.22910
- By:
- Publication type:
- Article
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells.
- Published in:
- Journal of Cellular Physiology, 2011, v. 226, n. 9, p. 2279, doi. 10.1002/jcp.22564
- By:
- Publication type:
- Article
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL).
- Published in:
- Journal of Cellular Physiology, 2010, v. 222, n. 2, p. 357, doi. 10.1002/jcp.21960
- By:
- Publication type:
- Article
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27<sup>Kip1</sup> accumulation in pre-osteoclast precursors.
- Published in:
- Journal of Cellular Physiology, 2008, v. 214, n. 1, p. 117, doi. 10.1002/jcp.21165
- By:
- Publication type:
- Article
Involvement of TRAIL/TRAIL-receptors in human intestinal cell differentiation<FNR></FNR><FN>Erika Rimondi and Paola Secchiero has contributed equally. </FN>.
- Published in:
- Journal of Cellular Physiology, 2006, v. 206, n. 3, p. 647, doi. 10.1002/jcp.20512
- By:
- Publication type:
- Article
New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: Recent advances.
- Published in:
- 2020
- By:
- Publication type:
- journal article
miRNAs as Influencers of Cell–Cell Communication in Tumor Microenvironment.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 1, p. 1, doi. 10.3390/cells9010220
- By:
- Publication type:
- Article
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?
- Published in:
- Clinical Science, 2019, v. 133, n. 10, p. 1145, doi. 10.1042/CS20181116
- By:
- Publication type:
- Article
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease.
- Published in:
- PLoS ONE, 2018, v. 13, n. 9, p. 1, doi. 10.1371/journal.pone.0203716
- By:
- Publication type:
- Article
Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells.
- Published in:
- Journal of Neurochemistry, 2003, v. 86, n. 1, p. 126, doi. 10.1046/j.1471-4159.2003.01805.x
- By:
- Publication type:
- Article
Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 15, p. 8098, doi. 10.3390/ijms25158098
- By:
- Publication type:
- Article
Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 4, p. 2124, doi. 10.3390/ijms25042124
- By:
- Publication type:
- Article
Convolvulus pluricaulis Choisy's Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model.
- Published in:
- Nutrients, 2023, v. 15, n. 7, p. 1727, doi. 10.3390/nu15071727
- By:
- Publication type:
- Article